#JPM26 #Obesity #Biotech #ResalisTherapeutics #MetabolicHealth To view or add a comment, sign in Had a blast discussing the "Weight-loss Olympics" with the GREAT Stephen Hansen last week
We therefore set out to examine whether treatment with GLP-1 receptor agonists is associated with a different incidence of rheumatic diseases compared to DPP-4 inhibitors, another common class of diabetes medications. To that end, Ibis and colleagues conducted a propensity score-matched cohort study using data from the TriNetX Analytics Network
Furthermore, patients with lung and kidney malignancies who had a poor response to PD-1 blocking had a decreased proportion of Akkermansiamuciniphila in their stomach, according to studies (Routy et al., 2018)
You can use the peptide reconstitution calculator to determine your preferred concentration
Regular follow-up appointments, typically scheduled every 4 to 12 weeks during the initial treatment phase, allow for dose adjustments, side effect management, and monitoring of therapeutic outcomes
The role of red cell distribution width (RDW), RDW/platelet ratio, and mean platelet volume as prognostic markers in acute pancreatitis severity and complications based on the bedside index for severity in acute pancreatitis score